Released May 10, 2022, after the close
10-Q filed May 10, 2022, 40 days after period end · 0001636422-22-000024
Q1 2022 · 10-Q
Revenue$68.09M$68.09M +21.9% vs Q1 2021+5.2% vs Q4 2021
Net Income-$22.46M-$22.46M N/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$0.54-$0.54 N/M vs Q1 2021no prior Q4 2021 on file
Operating Income-$24,347,000N/M
Operating Cash Flow$1,158,000N/M
Free Cash Flowderived$802,000N/M
Margins · derived
Operating margin-35.8%+7.8 pt vs Q1 2021
Net margin-33.0%+17.8 pt vs Q1 2021
What the release said
The release
Same quarter
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $68.09M | $55.85M | $45.12M | $35.21M |
| Net Income | -$22.46M | -$28.37M | -$17.49M | -$13.72M |
| EPS Diluted | -$0.54 | -$0.65 | -$0.47 | -$16.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR